BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Latest Pharma Insights



Winter Is Coming: CHC Firms Battle It Out In Germany’s Crowded Cough And Cold Market
Consumer healthcare firms large and small will fight it out this winter for dominance in Germany's OTC cough and cold...
HBW Insight - September 20, 2019
Health And Wellness Products Trademark Review 17 September, 2019
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the...
HBW Insight - September 20, 2019
Pipeline Watch: Phase II Starts In Hearing Loss, Type 1 Diabetes
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...
Scrip - September 20, 2019
Gene Profiling Identifies Drugs For Childhood Cancers But Access A Problem
Lack of infrastructure for identifying mutations and access routes is holding back use of targeted medicines in children with cancer
Scrip - September 20, 2019
Longer Medicine Supply Delays Expected In No-Deal Brexit
Delays in the delivery of medicines with short lead times will be longer than originally expected in the event of...
Pink Sheet - September 20, 2019
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Pink Sheet - September 20, 2019
Laurus Buys Way Into South African ARV Tenders
India’s Laurus Labs is aiming to supply antiretrovirals through South Africa’s public tender system after agreeing a deal to buy...
Pink Sheet - September 20, 2019
Device Week, 20 September, 2019 – Medtech Giants Sign Major Diabetes Partnerships
In this edition of Device Week, Medtech Insight’s Catherine Longworth chats to Marion Webb about two new major partnerships signed...
Medtech Insight - September 20, 2019
Emmaus Fumes After EMA Rejects Sickle Cell Drug Again
The US firm has withdrawn its submission to get EU approval for Xyndari. After being turned down by the CHMP...
Scrip - September 20, 2019
Shortlist Revealed For Industry Awards
Shortlists for each of the 14 categories in the Global Generics & Biosimilars Awards 2019 have been announced, after our...
Pink Sheet - September 20, 2019
Brexit and UK Procurement: Be Ready For Day One
There are six weeks or less for medtech companies to be ready to operate as well as they can under...
Medtech Insight - September 20, 2019
C-Suite Snippets: A Fresh View From Old Science
In case you missed it: catch up with snippets from interviews published by In Vivo this month.
In Vivo - September 20, 2019
Have EU Rules For Designating MDR Expert Panels Been Published Soon Enough?
Expert panels will play a vital role in the implementation of the EU’s Medical Device Regulation, including in the oversight...
Medtech Insight - September 20, 2019
QUOTED. 20 September 2019. Eran Atlas.
Tel-Aviv, Isreal-based DreaMed Diabetes received another US Food and Drug Administration clearance for its AI-powered Advisor Pro software, which helps...
Medtech Insight - September 20, 2019
Brighter News For Varlitinib As Results In Tough Cancer Type Encourage ASLAN
Following a major setback in another indication earlier this year, ASLAN’s lead asset is now seen as a potential new...
Scrip - September 20, 2019

Pipeline Watch: Phase II Starts In Hearing Loss, Type 1 Diabetes
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...
Scrip - September 20, 2019
Gene Profiling Identifies Drugs For Childhood Cancers But Access A Problem
Lack of infrastructure for identifying mutations and access routes is holding back use of targeted medicines in children with cancer
Scrip - September 20, 2019
Emmaus Fumes After EMA Rejects Sickle Cell Drug Again
The US firm has withdrawn its submission to get EU approval for Xyndari. After being turned down by the CHMP...
Scrip - September 20, 2019
Brighter News For Varlitinib As Results In Tough Cancer Type Encourage ASLAN
Following a major setback in another indication earlier this year, ASLAN’s lead asset is now seen as a potential new...
Scrip - September 20, 2019

Longer Medicine Supply Delays Expected In No-Deal Brexit
Delays in the delivery of medicines with short lead times will be longer than originally expected in the event of...
Pink Sheet - September 20, 2019
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Pink Sheet - September 20, 2019
Laurus Buys Way Into South African ARV Tenders
India’s Laurus Labs is aiming to supply antiretrovirals through South Africa’s public tender system after agreeing a deal to buy...
Pink Sheet - September 20, 2019
Shortlist Revealed For Industry Awards
Shortlists for each of the 14 categories in the Global Generics & Biosimilars Awards 2019 have been announced, after our...
Pink Sheet - September 20, 2019

C-Suite Snippets: A Fresh View From Old Science
In case you missed it: catch up with snippets from interviews published by In Vivo this month.
In Vivo - September 20, 2019

Device Week, 20 September, 2019 – Medtech Giants Sign Major Diabetes Partnerships
In this edition of Device Week, Medtech Insight’s Catherine Longworth chats to Marion Webb about two new major partnerships signed...
Medtech Insight - September 20, 2019
Brexit and UK Procurement: Be Ready For Day One
There are six weeks or less for medtech companies to be ready to operate as well as they can under...
Medtech Insight - September 20, 2019
Have EU Rules For Designating MDR Expert Panels Been Published Soon Enough?
Expert panels will play a vital role in the implementation of the EU’s Medical Device Regulation, including in the oversight...
Medtech Insight - September 20, 2019
QUOTED. 20 September 2019. Eran Atlas.
Tel-Aviv, Isreal-based DreaMed Diabetes received another US Food and Drug Administration clearance for its AI-powered Advisor Pro software, which helps...
Medtech Insight - September 20, 2019

Winter Is Coming: CHC Firms Battle It Out In Germany’s Crowded Cough And Cold Market
Consumer healthcare firms large and small will fight it out this winter for dominance in Germany's OTC cough and cold...
HBW Insight - September 20, 2019
Health And Wellness Products Trademark Review 17 September, 2019
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the...
HBW Insight - September 20, 2019

E25Bio gets $2.3mm via seed round
Diagnostics start-up E25Bio Inc. raised $2.3mm in a seed financing round led by The Engine, which was joined by Alumni Ventures Group and angel investor Alejandro Chavez. According to the Form D, seven investors participated.
Strategic Transactions - August 30, 2019
Back to the top Back to the top